Centre de presse

Bienvenue au centre de presse de
Boehringer Ingelheim (Schweiz) GmbH

Vous trouverez ici une vue d’ensemble de tous les communiqués de presse actuels sur l’entreprise.

retour 1 2 3 4 5 prochaine

24.04.2012	Boehringer Ingelheim sur la voie de la croissance - Année financière 2011 réussie
06.10.2011	Boehringer Ingelheim and Gilead sign license agreement for novel HIV non-catalytic integrase inhibitors
27.09.2011	BIBF 1120* in patients with metastatic colorectal cancer as effective as bevacizumab with less serious adverse events - FOR NON-US MEDIA ONLY
26.09.2011	Boehringer Ingelheim expands its Business with Biosimilars
22.09.2011	New Study Published in New England Journal of Medicine Shows Investigational BIBF 1120 Demonstrated Positive Trend in Reducing Lung Function Loss in Idiopathic Pulmonary Fibrosis - For NON-U.S Health Media Only